Can LL-37 Truncated Variants (KR-12 / KS-30) and IGF-1 LR3 be stacked together?

Some peptide pairs in different categories (e.g., recovery + cognitive) are commonly stacked. Others overlap mechanistically and shouldn't be combined. Always consult a licensed physician before stacking compounds.

Side-by-side comparison

LL-37 Truncated Variants (KR-12 / KS-30) vs IGF-1 LR3

Q: What is the main difference between LL-37 Truncated Variants (KR-12 / KS-30) and IGF-1 LR3?

LL-37 Truncated Variants (KR-12 / KS-30) is primarily classified as a recovery compound (shorter active fragments of ll-37 (kr-12, ks-30) with retained antimicrobial activity but lower toxicity.). IGF-1 LR3 is a performance compound (growth mediator.).

Shorter active fragments of LL-37 (KR-12, KS-30) with retained antimicrobial activity but lower toxicity. versus Growth Mediator.

LL-37 Truncated Variants (KR-12 / KS-30)

Recovery

Shorter active fragments of LL-37 (KR-12, KS-30) with retained antimicrobial activity but lower toxicity.

Top benefits

✓Antimicrobial activity preserved
✓Lower hemolysis vs full LL-37
✓Wound healing research

Full LL-37 Truncated Variants (KR-12 / KS-30) guide→

IGF-1 LR3

Performance

Growth Mediator.

Top benefits

✓Muscle hyperplasia
✓Fat loss
✓Recovery

Full IGF-1 LR3 guide→

Attribute	LL-37 Truncated Variants (KR-12 / KS-30)	IGF-1 LR3
Category	Recovery	Performance
Type	linear	protein
Chain length	12 aa	83 aa
Formula	KR-12 fragment of LL-37	C400H625N111O115S9
Common dose	Not established	20-50 mcg
Frequency	N/A	Daily (post-workout)
Top benefit	Antimicrobial activity preserved	Muscle hyperplasia
Top side-effect	Localized irritation (topical)	Hypoglycemia

⚠

Educational use only

This calculator is provided for research and educational purposes. Outputs are derived from the values you enter. Always verify your math and consult a licensed physician before acting on any result.